首页> 外文期刊>眼科学报(英文版) >Toric Intraocular Lens vs. Peripheral Corneal Relaxing Inci-sions to Correct Astigmatism in Eyes Undergoing Cataract Surgery
【24h】

Toric Intraocular Lens vs. Peripheral Corneal Relaxing Inci-sions to Correct Astigmatism in Eyes Undergoing Cataract Surgery

机译:复曲面人工晶状体与周围角膜松弛术矫正白内障手术后眼睛的散光

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose:.To compare toric intraocular lens implantation (Toric-IOL).with peripheral corneal relaxing incisions (PCRIs) for astigmatism correction in patients undergoing cataract surgery. Methods: 54 patients (54 eyes) with more than 0.75 diopter (D).of preexisting corneal astigmatism were classified as group A (0.75-1.50D) or group B (1.75-2.50D). The patients were randomized to undergo Toric-IOL or PCRIs in the steep axis with spherical IOL implantation..LogMAR uncorrected visual acuity (LogMAR UCVA), LogMAR best corrected vi sual acuity.(LogMAR BCVA),.error of vector (|EV|), surgery induced refraction correction. (|SIRC|),.and correction rates (CR) were measured 1 month and 6 months postoperatively. Results: At 6 months postoperatively, all 54 eyes had Log-MAR BCVA≤0.2. Patients who underwent PCRIs and Toric-IOL with LogMAR BCVA≤0.1 showed no significant differ-ences in group A (P=1.00) or in group B (P=0.59). Group A showed no significant differences in LogMAR UCVA (P=0.70), |EV| (P=0.13), |SIRC| (P=0.71), and CR (P=0.56) in patients underwent PCRIs and Toric-IOL. However, group B showed significant differences in LogMAR UCVA (P<0.01), |EV| (P<0.01)), |SIRC| (P<0.01), and CR (P<0.01). The LogMAR UCVA and |EV| between 1 and 6 months showed no significant differences in patients in group A. How-ever, in group B, they are significant differences. Conclusion:.The efficacy and stability of Toric-IOL and PCRIs were equal in low astigmatic patients..Toric-IOL achieved an enhanced effect over PCRIs in higher astigmatic patients. PCRIs had the more refractive regression than Toric-IOL in 6 months.
机译:目的:比较在进行白内障手术的患者中使用散光矫正散光的人工晶状体植入术(Toric-IOL)和外周角膜松弛切口(PCRIs)。 方法:54例(54眼)屈光度(D)大于0.75的患者,既往存在角膜散光,分为A组(0.75-1.50D)或B组(1.75-2.50D)。患者随机接受球面人工晶状体植入在陡轴上接受Toric-IOL或PCRIs治疗。LogMAR未矫正视力(LogMAR UCVA),LogMAR最矫正视力(LogMAR BCVA),.向量误差(| EV | ),手术引起的屈光矫正。 (| SIRC |)。和术后1个月和6个月的矫正率(CR)。 结果:术后6个月,所有54只眼的Log-MAR BCVA≤0.2。 LogMARBCVA≤0.1的接受PCRIs和Toric-IOL的患者在A组(P = 1.00)或B组(P = 0.59)中无显着差异。 A组在LogMAR UCVA中无显着差异(P = 0.70),| EV | (P = 0.13),| SIRC | (P = 0.71)和CR(P = 0.56)接受PCRIs和Toric-IOL的患者。但是,B组在LogMAR UCVA中显示出显着差异(P <0.01),| EV |。 (P <0.01)),| SIRC | (P <0.01)和CR(P <0.01)。 LogMAR UCVA和| EV | A组患者在1至6个月之间无显着差异。然而,B组患者则有显着差异。 结论:.Toric-IOL和PCRIs在低散光患者中的疗效和稳定性相同。.Toric-IOL在较高散光患者中的效果优于PCRIs。在6个月内,PCRI比Toric-IOL的屈光退缩更大。

著录项

  • 来源
    《眼科学报(英文版)》 |2014年第004期|198-203|共6页
  • 作者单位

    Department of 0phthalmology, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China.;

    Department of 0phthalmology, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China.;

    State Key Laboratory of 0phthalmology, Zhongshan 0phthalmic Center, Sun Yat-sen University, Guangzhou 510060, China;

    State Key Laboratory of 0phthalmology, Zhongshan 0phthalmic Center, Sun Yat-sen University, Guangzhou 510060, China;

    Department of 0phthalmology, Dyson Vision Research Institute, Weill Cornell Medical College, New York 10065, USA;

    State Key Laboratory of 0phthalmology, Zhongshan 0phthalmic Center, Sun Yat-sen University, Guangzhou 510060, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 03:45:15
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号